UPDATE: JP Morgan Downgrades Health Care REIT to Overweight on Valuation
JP Morgan downgraded Health Care REIT (NYSE: HCN) from Overweight to Neutral and maintained a $63.00 price target.
JP Morgan noted, "We are downgrading HCN to Neutral from Overweight. This call is a relative stock call as we continue to view the fundamental prospects and growth outlook for HCN favorably. We simply hold a bias toward more economically leveraged property types at this time and see near-term catalysts elsewhere in the REIT sector. … HCN trades at 15.9x our 2013 FFO estimate, a 3% premium to the healthcare group average."
Health Care REIT closed at $61.31 on Tuesday.
Latest Ratings for HCN
|Mar 2017||Morgan Stanley||Upgrades||Equal-Weight||Overweight|
|Jan 2017||SunTrust Robinson Humphrey||Downgrades||Buy||Hold|
|Jan 2017||Mitsubishi UFJ||Upgrades||Neutral||Overweight|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.